Applied Therapeutics Inc (APLT)
0.7449
-0.06
(-7.12%)
USD |
NASDAQ |
Jan 08, 13:19
Applied Therapeutics Research and Development Expense (Annual): 53.90M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Ionis Pharmaceuticals Inc | 899.62M |
Cassava Sciences Inc | 89.42M |
Verastem Inc | 61.36M |
Cellectar Biosciences Inc | 27.27M |
Aptevo Therapeutics Inc | 17.11M |